Ayuda
(especial para SIIC © Derechos reservados)

Crónicas de autores

Alfredo Eduardo Rodriguez*
Autor invitado por SIIC

Relación con el uso de sistemas de protección cerebral

Cronicas de autores PRONOSTICO HOSPITALARIO Y A LARGO PLAZO DE LOS PACIENTES CON STENT CAROTIDEO

Este estudio demuestra que la angioplastia carotídea es un procedimiento aceptable, con una baja tasa de complicaciones agudas en pacientes con indicación de revascularización carotídea; estos resultados se mantuvieron en el tiempo. En esta serie de casos, el uso de dispositivos de protección de embolias no se asoció con mejores resultados.
*Alfredo Eduardo Rodriguez
describe para SIIC los aspectos relevantes de su trabajo
RESULTADOS HOSPITALARIOS Y ALEJADOS DEL STENT CAROTIDEO DE UNA SERIE CONSECUTIVA: RELACION CON EL USO DE SISTEMAS DE PROTECCION CEREBRAL

Revista Argentina de Cardioangiología Intervencionista (RACI),
5(3):197-202

Esta revista, clasificada por SIIC Data Bases, integra el acervo bibliográfico
de la Biblioteca Biomédica (BB) SIIC.
Institución principal de la investigación
*Sanatorio Otamendi y Miroli, Buenos Aires, Ar
a-livro3.gif
Profundizar



Referencias bibliográficas
Rothwell PM, Eliasziw M, Gutnikov SA, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 361:107-116, 2003.
Touze M, Trinquart M, Chatellier G, et al. Sistematic reviw of the perioperative riscks of stroke or death after carotid angioplasty and stenting. Stoke 40:683-93, 2009.
Pocovi A. State of the art for the revascularization treatment of the extra craneal internal carotid artery. Carotid angioplasty role in light of randomized trials. Revista Argentina de Cardioangiología 3(3):147-160, 2012.
Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Transluminal Angioplasty Study (CAVATAS): A randomised trial. Lancet 357:1729-1737, 2001.
Rodriguez A, Cristino A, Fernandez M y col. Non surgical revascularization in brachiocefalic vessels: Role of percutaneous transluminal angioplasty. Eur Heart J 14:1428, 1993.
Rodriguez A, Fernandez M, Mele E et al. Non surgical revascularization in carotid arteries: Role of percutaneous transluminal angioplasty. J Am Coll Cardiol 380:796-801, 1995.
Orlandi G, Fanucchi S, Fioretti C et al. Characteristics of cerebral microembolism during carotid stenting and angioplasty alone. Arch Neurol 58:1410-1413, 2001.
Bonaldi G. Angioplasty and stenting of the cervical carotid bifurcation: report of a 4-year series. Neuroradiology 44:164-174, 2002.
Jaeger HJ, Mathias KD, Hauth E, et al. Cerebral ischemia detected with diffusion-weighted MR imaging after stent implantation in the carotid artery. AJNR Am J Neuroradiol 23:200-207, 2002.
Parodi JC, La Mura R, Ferreira LM, et al. Initial evaluation of carotid angioplasty and stenting with three diff erent cerebral protection devices. J Vasc Surg 32:1127-1136, 2000.
Qureshi AI, Suri MF, New G, et al. Multicenter study of the feasibility and safety of using the Memotherm carotid arterial stent for extracranial carotid artery stenosis. J Neurosurg 96:830-836, 2002.
Roubin GS, New G, Iyer SS, et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation 103:532-537, 2001.
Cremonesi A, Castriota F, Manetti R, et al. Endovascular treatment of carotid atherosclerotic disease: early and late outcome in a non-selected population. Ital Heart J 1:801-809, 2000.
D'Audiffret A, Desgranges P, Kobeiter H, Becquemin JP. Technical aspects and current results of carotid stenting. J Vasc Surg 33:1001-1007, 2001.
Diethrich EB, Ndiaye M, Reid DB. Stenting in the carotid artery: initial experience in 110 patients. J Endovasc Surg 3:42-62, 1996.
Gupta A, Bhatia A, Ahuja A, et al. Carotid stenting in patients older than 65 years with inoperable carotid artery disease: a single-center experience. Catheter Cardiovasc Interv 50:1-8, 2000.
Malek AM, Higashida RT, Phatouros CC, et al. Stent angioplasty for cervical carotidartery stenosis in high-risk symptomatic NASCET-ineligible patients. Stroke 31:3029-3033, 2000.
Van Der Hayden J, Wolters FJ, Garin N, et al. The role of embolic protection devices during carotid stenting prior to cardiac surgery in asymptomatic patients: empty filter. Catheter Cardioivasc Interv 80(1):112-9, 2012.
Macdonald S, Evans DH, Griffi ths PD, et al. Filter-protected versus unprotected carotid artery stenting: a randomised trial. Cerebrovasc Dis 29(3):282-9, 2010.
Barbato JE, Dillavou E, Horowitz MB, et al. A randomized trial of carotid artery stenting with and without cerebral protection. J Vasc Surg 47(4):760-5, 2008.
Cilingiroglu M. Asymptomatic carotid artery stenting: Filter or no filter? Catheter Cardiovasc Interv 80(1):120, 2012.
Roubin GS, New G, Iyer SS et al. Inmediate and late clinical outcomes of carotid artery stenting in patient with symptomatic and asymptomatic carotid artery stenosis, a 5 year prospective analysis. Circulation 103:532-537, 2001.
Dawkins AA, Evans AL, Wattam J, et al Complications of cerebral angiography: a prospective analysis of 2,924 consecutive procedures. Neuroradiology 49(9):753-9, 2007.
Naylor AR, Mehta Z, Rothwell PM, et al. Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature Eur J Vasc Endovasc Surg 23:283-294, 2002.
Wiesmann M, Schopf V, Jansen O, Bruckmann H. Stent protected angioplasty versus carotid endarterectomy in patients with carotid artery stenosis: meta- analysis of randomized trial data. Eur Radiol 18:2956-2966, 2008.
Ringleb PA, Allenberg J, Bruckmann H, et al. SPACE Collaborative Group. 30 day results from the SPACE trial of stent protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non - inferiority trial. Lancet 368:1238, 2006.
Kastrup A, Groschel K, Krapf H, et al. Early outcome of carotid angioplasty and stenting with and without cerebral protection device: a systemic review of the literature. Stoke 2003; 34: 813-9.
Reimers B, Corvaja N, Moshiri S, et al. Cerebral protection with fi lter devices during carotid artery stenting. Circulation. 2001;104:12-15.
Cremonesi A, Manetti R, Castriota F, Setacci F. Protected carotid stenting: clinical adventages and complications of embolic protection devices in 442 consecutive patients. Stroke 34:1936-1943, 2003.
Jansen O, Fiehler J, Hartmann M, Bruckmann H. Protection or noprotection in carotid angioplasty. The infl uence of interventional Techniques on outcome data from the SPACE trial. Stroke 40:841-846, 2009.
Duda SH, Wiskirchen J, Tepe G, et al. Physical properties of endovascular stents: an experimental comparision. J Vasc Interv Radiol 11:645-654, 2000.
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 325:445-53, 1991.
Bonati LH, Dobson J, Featherstone R et al. Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial. doi:10.1016/S0140-6736(14)61184-3.
Brooks WH, Jones MR, Gisler P et al. Carotid Angioplasty With Stenting Versus Endarterectomy: 10-Year Randomized Trial in a Community Hospital. J Am Coll Cardiol Intv 7(2):163-168, 2014.
Otros artículos de Alfredo Eduardo Rodriguez
Dangas GD, Farkouh ME, Sleeper LA, Yang M, Schoos MM, Macaya C, Abizaid A, Buller CE, Devlin G, Rodriguez AE, Lansky AJ, Siami FS, Domanski M, Fuster V; FREEDOM Investigators. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial. J Am Coll Cardiol 64(12):1189-97, 2014.
Rodriguez AE, Palacios I, Rodriguez-Granillo AM, Mieres JR, Tarragona S, Fernandez-Pereira C, Solorzano L, Pauletto R, Serruys PW, Antoniucci D; ORAR-3 investigators. Comparison of cost-effectiveness of oral rapamycin plus bare-metal stents versus first generation of drug-eluting stents (from the Randomized Oral Rapamycin in Argentina [ORAR] 3 trial). Am J Cardiol 113(5):815-21, 2014.
Garg S, Sarno G, Serruys PW, Rodriguez AE, Bolognese L, Anselmi M, De Cesare N, Colangelo S, Moreno R, Gambetti S, Monti M, Bristot L, Bressers M, Garcia-Garcia HM, Parrinello G, Campo G, Valgimigli M; STRATEGY and MULTISTRATEGY Investigators. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. JACC Cardiovasc Interv 4(1):66-75, 2011.
Migliorini A, Stabile A, Rodriguez AE, Gandolfo C, Rodriguez Granillo AM, Valenti R, Parodi G, Neumann FJ, Colombo A, Antoniucci D; JETSTENT Trial Investigators. Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial. J Am Coll Cardiol 56(16):1298-306, 2010.
Rodriguez AE, Maree A, Tarragona S, Fernandez-Pereira C, Santaera O, Rodriguez Granillo AM, Rodriguez-Granillo GA, Russo-Felssen M, Kukreja N, Antoniucci D, Palacios IF, Serruys PW; ORAR III Investigators. Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study. EuroIntervention 5(2):255-64, 2009.
Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, Carrié D, Clayton TC, Danchin N, Flather M, Hamm CW, Hueb WA, Kähler J, Kelsey SF, King SB, Kosinski AS, Lopes N, McDonald KM, Rodriguez A, Serruys P, Sigwart U, Stables RH, Owens DK, Pocock SJ. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 373(9670):1190-7, 2009.
Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, Rodriguez-Granillo G, Hueb WA, Lemos PA, Serruys PW. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 118(11):1146-54, 2008.
Rodriguez AE, Grinfeld L, Fernandez-Pereira C, Mieres J, Rodriguez Alemparte M, Berrocal D, Rodriguez-Granillo AM, Vigo CF, Russo Felsen M, O'Neill W, Palacios I. Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III Trial. EuroIntervention 2(1):53-60, 2006.
Rodriguez AE, Baldi J, Fernández Pereira C, Navia J, Rodriguez Alemparte M, Delacasa A, Vigo F, Vogel D, O'Neill W, Palacios IF; ERACI II Investigators. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol 46(4):582-8, 2005.
Rodríguez AE. The role of acute wall recoil and late restenosis: results of the OCBAS trial (Optimal Coronary Balloon Angioplasty with Provisional Stenting versus Primary Stent). Int J Cardiovasc Intervent 4(2):99-106, 2001.
Autor invitado
4 de noviembre, 2014
Descripción aprobada
18 de noviembre, 2014
Reedición siicsalud
8 de mayo, 2017

Acerca del trabajo completo
PRONOSTICO HOSPITALARIO Y A LARGO PLAZO DE LOS PACIENTES CON STENT CAROTIDEO
Título original en castellano
Autores
Alfredo Eduardo Rodriguez1, Roberto Cristodulo Cortez2, Benjamin Ugarte3, Jhon Aldana Robinson4, Alfredo M Rodriguez Granillo5, Carlos Fernandez Pereira6, Carlos Mauvecin7, Juan Mieres8
1 Md, Phd, Sanatorio Otamendi y Miroli, Buenos Aires, Ar, Director
2 Md, Sanatorio Otamendi y Miroli, Fellow
3 Md, Sanatorio Las Lomas, Fellow
4 Md, Clinica Ima, Fellow
5 Md, Centro de Estudios en Cardiologia Intervencionista, Staff
6 Md, Phd, Sanatorio Otamendi y Miroli, Staff
7 Md, Clinica Ima, Staff
8 Md, Sanatorio Las Lomas, Staff
Acceso a la fuente original
Revista Argentina de Cardioangiología Intervencionista (RACI)
http://www.caci.org.ar/default.asp?xItem=876
El artículo se relaciona estrictamente con las especialidades de siicsalud

 Principal 1


 Principal 2

El artículo se conecta secundariamente con las especialidades
  
anterior.gif (1015 bytes)
ua90911

Bienvenidos a siicsalud

Acerca de SIIC     Estructura de SIIC

Sociedad Iberoamericana de Información Científica (SIIC)
Av. Belgrano 430, (C1092AAR), ciudad de Buenos Aires, Argentina
Tel: +54 11 4342 4901
Casilla de Correo 2568, (C1000WAZ) Correo Central, ciudad de Buenos Aires
Copyright siicsalud© 1997-2017, Sociedad  Iberoamericana de Información Científica (SIIC)
ISSN siicsalud: 1667-9008
ua4711
Mensajes a SIIC